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Abstract
Despite significant advances in tissue engineering such as the use of scaffolds, bioreactors
and pluripotent stem cells, effective cardiac tissue engineering for therapeutic purposes has
remained a largely intractable challenge. For this area to capitalise on such advances, a
novel approach may be to unravel the physiological mechanisms underlying the develop-
ment of tissues that exhibit rhythmic contraction yet do not originate from the cardiac line-
age. Considerable attention has been focused on the physiology of the avian lymph heart, a
discrete organ with skeletal muscle origins yet which displays pacemaker properties nor-
mally only found in the heart. A functional lymph heart is essential for avian survival and
growth in ovo. The histological nature of the lymph heart is similar to skeletal muscle
although molecular and bioelectrical characterisation during development to assess mecha-
nisms that contribute towards lymph heart contractile rhythmicity have not been undertaken.
A better understanding of these processes may provide exploitable insights for therapeutic
rhythmically contractile tissue engineering approaches in this area of significant unmet clini-
cal need. Here, using molecular and electrophysiological approaches, we describe the
molecular development of the lymph heart to understand how this skeletal muscle becomes
fully functional during discrete in ovo stages of development. Our results show that the
lymph heart does not follow the normal transitional programme of myogenesis as docu-
mented in most skeletal muscle, but instead develops through a concurrent programme of
precursor expansion, commitment to myogenesis and functional differentiation which offers
a mechanistic explanation for its rapid development. Extracellular electrophysiological field
potential recordings revealed that the peak-to-peak amplitude of electrically evoked local
field potentials elicited from isolated lymph heart were significantly reduced by treatment
with carbachol; an effect that could be fully reversed by atropine. Moreover, nifedipine and
cyclopiazonic acid both significantly reduced peak-to-peak local field potential amplitude.
Optical recordings of lymph heart showed that the organ’s rhythmicity can be blocked by the
HCN channel blocker, ZD7288; an effect also associated with a significant reduction in
peak-to-peak local field potential amplitude. Additionally, we also show that isoforms of
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HCN channels are expressed in avian lymph heart. These results demonstrate that choliner-
gic signalling and L-type Ca2+ channels are important in excitation and contraction coupling,
while HCN channels contribute to maintenance of lymph heart rhythmicity.
Introduction
The lymph heart is a small oval, hollow organ, the contractions of which assist the flow of
lymph. In fish, reptiles, amphibians and birds, the lymph heart actively pumps lymph through-
out the lymphatic system and into the veins [1]. In many birds, lymph hearts are functional
only during embryonic life and, after hatching, degenerate since their function is superseded
by skeletal muscle contractions and respiration-induced pressure fluctuations [2]. In contrast,
in amphibians, several lymph hearts are present that remain functional into adult life [1].
As such, study of the molecular and functional features underlying the unique behaviours
of the avian lymph heart’s development, rhythmicity and termination could offer useful and
exploitable insights into therapeutic tissue engineering. In this regard, cardiac tissue engineer-
ing remains a significant challenge with heart disease accounting for ~40% of all deaths [3]
and heart transplant, with its accompanying challenges, representing the only treatment
approach for end stage heart disease patients [4]. While experimental advances, such as the
identification of potential progenitor cell populations in cardiac tissue and the development of
biocompatible scaffolds and bioreactors that could support organ growth [5–7] have been
made in recent years, a detailed understanding of the unique molecular mechanisms at play
during development that give rise to tissues with functionally rhythmic properties remain rela-
tively poorly understood [8].
Avian lymph heart comprises three layers: an inner endothelial cell layer lining the organ’s
cavity, an outer layer of fibrous connective tissue that facilitates attachment of the lymph heart
to the vertebral column and a middle layer of muscle fibres which are highly branched and of
smaller diameter reminiscent of cardiac muscle [9–11] Despite the cardiac similarity of myo-
tubes, lymph hearts only express skeletal muscle markers [10] and not determinants of cardiac
tissue, such as GATA-4, -5 and -6, and cardiac troponin [11]. Nevertheless, the organ exhibits
spontaneous, rhythmic contractions [10–13]. Thus, the lymph heart is unique as a skeletal
muscle that rhythmically contracts as a result of intrinsically generated action potentials [14]
and displays structural characteristics similar to cardiac heart [10, 11]. Importantly, the avian
lymph heart must be fully functional during in ovo development since its failure leads to
oedema and embryonic death [10]. This is in sharp contrast to other skeletal muscles that
remain relatively immature until after hatching. To our knowledge, no other studies have
investigated how lymph heart becomes fully functional at early stages of the organism’s
development.
Studies investigating electrical activity regulating the contraction of lymph hearts have
mainly been performed in frog where the phenomenon was first documented by Bruck and
Umrath [15], and later by Del Castillo and Sanchez [14]. Here, extracellular recordings via two
platinum electrodes revealed that the lymph heart contraction was associated with bursts of
electrical activity comprising 8–10 variable amplitude ‘action currents’ (local field potentials)
[14]. Furthermore, intracellular recordings from lymph heart muscle cells revealed summating
depolarisation followed by a later, sustained hyperpolarisation [14]. In addition, Del Castillo
and Sanchez [14] and Day et al. [16]investigated pharmacological modulation of amphibian
lymph heart electrophysiological properties to show that recorded activity was particularly
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sensitive to cholinergic modulators whilst subsequent studies revealed the presence of nico-
tinic acetylcholine receptors (nAChRs) in amphibian lymph heart [10, 17]. Thus, whilst the
bioelectrical basis of the amphibian lymph heart contraction is well known and can be modu-
lated via nAChRs in the same manner as skeletal muscle [10, 17], the underlying basis for
avian lymph heart rhythmicity in birds remains unknown.
Here, we provide molecular evidence that avian lymph heart develops through an accel-
erated process in which events of skeletal precursor expansion, commitment and function-
ality occur concurrently together with the formation of the endothelial compartment. We
postulate that hastened development is required so that the lymph heart acquires full func-
tionality in a short period of time. Furthermore, investigation of electrical activity of lymph
heart revealed that its excitability arises from an interplay of cholinergic receptors, voltage-
dependent Ca2+ channels (L -type), intracellular Ca2+ and HCN channels. Although dynam-
ics underlying rhythmicity may vary between avian lymph heart and cardiac pacemaker
cells, these results show that similar molecular mechanisms mediate rhythmic contractile
activity.
Materials and Methods
Whole-mount in situ hybridisation
Fertilised white eggs were obtained from Henry Stewart (UK) and incubated at 39˚C and 80%
humidity. Embryos at embryonic day (E) 6 (HH30), 8 (HH34), 10 (HH36) and 12 (HH38)
were decapitated and cut transversally below the thorax. The caudal part of the embryo was
skinned and fixed in 4% PFA for 12 hours or more. Dehydration in methanol (Fisher Scien-
tific, Loughborough, UK) was then carried out and tissue stored at -20˚C overnight. In situ
hybridisation was performed as described previously [18] with the following digoxigenin-
labelled probes: MyoD (1.5kb), Myogenin (1.2kb), Pax-7 (582bp), Cadherins (M (muscle)
(1.08kb), N (neural) (1.28kb), R (retinal) (1.6kb) and T (Heart) (931bp), En-1, Prox-1, L-type
Ca2+ channels (Cav 1.1; 468bp), HCN1 and HCN4 channels. Following whole mount in situ
hybridisation, embryos were fixed and photographed using a Nikon Coolpix digital camera
and image processing was performed with Adobe Photoshop CS3 to adjust for brightness, con-
trast and background.
Microelectrode arrays (MEA)
For MEA recordings, chick embryo pelvis was skinned at E10 (HH36), halved and one half of
the pelvis used to ensure consistent contact of the intact lymph heart with the array of 60 elec-
trodes. The pelvis was maintained in Kreb’s solution (containing 124mM NaCl, 3mM KCl,
1.25mM KH2PO4, 36mM NaHCO3, 1mM MgSO4, 10mM d-glucose and 2mM CaCl2). Prior to
recording, MEAs were cleaned with 5% (w/v) Terg-A-Zyme (Cole-Palmer, London, UK), and
finally distilled water before air drying. Tissues were adhered to MEAs using a harp with
lymph heart facing the bottom of the array. We used Nikon TS-51 microscope (Nikon, Japan)
at magnification ×4 to ascertain the position of the lymph heart. Images of tissue and electrode
positions were acquired using a Mikro-Okular camera (Meade Instruments Corp., CA, USA).
Once attached, tissues were maintained at 25˚C and were continually perfused with carboxyge-
nated (95% O2/5% CO2) Kreb’s solution (*2ml/min) and allowed to stabilize for at least 10
min prior to any recordings. Electrical activity across each tissue was monitored and recorded
using MEAs (59 electrodes each 30μm diameter with 200μm spacing and 100μm recording
radius. For stimulation, voltage pulses (STG2004, Multi-Channel Systems GmbH, Reutlingen,
Germany) of 250 mV amplitude and 100 μs duration were applied with a 5s interval between
pulses. Data acquisition was performed using MC Rack software (Multi Channel Systems
Developing Skeletal Muscle
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GmbH, Reutlingen, Germany). Initially, tissue viability and contact with MEA electrodes was
assessed by applying voltage pulses through MEA electrodes on the tissue. Once a reliable
extracellular field potential had been obtained, 5 stimuli were applied and responses recorded
for each electrode. Drugs were applied after recording reliable extracellular field potentials and
were perfused for 20–30 minutes before re-applying the same stimulus-recording protocol.
Signals were amplified (1200× gain), by a 120-channel dual headstage amplifier (MEA60 Sys-
tem, Multi-Channel Systems GmbH, Reutlingen, Germany) and simultaneously sampled at a
minimum of 10 kHz per channel on all 60 channels. Once the recording was completed, the
tissue still adhered onto MEA was kept at -20˚C for 5 minutes and a final recording was made.
Freezing kills the tissue and generates only a stimulus artefact in response to electrical stimula-
tion, allowing offline subtraction of the stimulus artefact from each recording. Data analysis
was performed using MC Rack (Multi Channel Systems GmbH, Reutlingen, Germany) and
parameters such as maximum, minimum and peak-to-peak amplitude were extracted. The
peak-to-peak amplitude of field potential was analysed for each electrode and data from indi-
vidual electrodes were pooled to provide mean results for each lymph heart before artefact sub-
traction as described above. Drug effects were assessed by comparing peak-to-peak amplitude
before and after drug application and results expressed as a normalised proportion of control
values. Statistical significance was determined by non-parametric Mann–Whitney U-test in
the case of all normalised data. In experiments where the effect of two drugs was tested, a non-
parametric Friedman’s test with post-hoc Dunn’s test was used. In all cases p 0.05 was con-
sidered to be significant.
Drugs
Nifedipine and tetrodotoxin (TTX) were obtained from Sigma–Aldrich (Poole, UK) and all
other drugs were obtained from Tocris (Abingdon, UK). The concentrations of the drugs were
as follows: atropine (5μM), carbachol (10μM), cyclopiazonic acid (CPA; 10μM), mibefradil
dihydrochloride (10μM) nifedipine (20μM), TTX (5μM) and ZD7288 (4-ethylphenylamino-1,
2-dimethyl-6-m-ethylaminopyrimidinium chloride; 20μM). All drugs were dissolved in water
except nifedipine (ethanol), CPA (DMSO) and TTX (citrate or acetate buffer at pH 4–5). Final
bath concentration of vehicle did not exceed 0.01%.
Optical recording of lymph heart beating
Chick embryo pelvis at E10 (HH36) were skinned and maintained in Tyrode’s solution (con-
taining 145mM NaCl, 1mM Glucose, 5mM HEPES, 5.9mM KCl, 1.25mM CaCl2 and 1.2mM
MgCl2.6H20) on a heated stage at a temperature of 39˚C or more to assess the beating of the
lymph heart. The position of the lymph heart was ascertained by observation on a Nikon
WD 70 microscope (Nikon, Japan) at magnification ×4 attached to Mikro-Okular camera
(Meade Instruments Corp., CA, USA). Lymph heart contractions were recorded using Arc-
Soft WebCam Companion 2 (ArcSoft., CA, USA). Pharmacological investigations were not
undertaken until a given lymph heart had exhibited robust beating for at least 5 minutes.
20μM of ZD7288 was then applied to determine the effect on lymph heart beating. The
recording was then made continuously for 15–25 minutes until the lymph heart stopped
beating due to the effect of drug administration. For quantification, video files generated
were exported to Image J (NIH software) and beats were counted manually for the duration
of the whole video. In addition, using Image J, a z-axis profile was plotted for lymph heart
beating for each recording.
Developing Skeletal Muscle
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Results
Whole-mount in situ hybridisation results
In order to understand the molecular mechanisms underpinning the development of the
lymph heart, we first examined the temporal and spatial relationship between genes that con-
trol the early stages of muscle differentiation. During development of skeletal muscle, specifi-
cally limbs and trunk, myogenic precursors express members of the paired box family of
transcription factors such as Pax-3 and Pax-7 [19]. Commitment to myogenic lineage during
development is signified by upregulation of MyoD and downregulation of Pax-7, and during
terminal differentiation of myogenic precursors, Myogenin, is additionally expressed [20].
During lymph heart development, the expression of Pax-7 was first detected at HH30 and, by
HH38, its expression level was just detectable (Fig 1A1–1A4 and 1A1.1–1A4.1). It is notewor-
thy that during these stages, expression of Pax-7 in axial and limb muscle was maintained at
high levels (Fig 1A1–1A4). The expression of MyoD was detected at HH30 but, in contrast to
Pax-7, its expression peaked at HH34 and, by HH38, had declined markedly (Fig 1B1–1B4 and
1B1.1–1B4.1). Surprisingly, the expression of Myogenin was detected as early as HH30 and was
maintained until HH38 (Fig 1C1–1C4 and 1C1.1–4.1).
Recent work has shown the development of amphibian lymph heart is dependent on the
expression of En-1 [11]. We therefore examined the expression of the avian homologue and
found that, unlike MyoD, this gene was not expressed in developing limb or branchial arches
(Fig 2A1–1A4). However, during development of lymph heart, En-1 was highly expressed at
HH30, HH34 and HH36 but, by HH38, its expression was not detectable (Fig 1D1–1D4 and
1D1.1–1D4.1). It is notable that expression of En-1 had ceased in the epaxial region by HH30.
The expression of cadherins during lymph heart development was also assessed. M-cadherin
is expressed in all muscle precursors (Fig 2B2–2B4). In the lymph heart, we found that M-cad-
herin was first detected at HH30 and by HH34 its expression was homogenous throughout the
lymph heart. By HH38, its expression declined and was concentrated only at the border of the
lymph heart (Fig 3A1–3A4 and 3A1.1–3A4.1). In most muscles the expression of other cadher-
ins, especially N- and R-Cadherin are initiated after M-cadherin. Here, we found that the
expression of N- and R-cadherin was confined to the outermost rim of the lymph heart with lit-
tle or no expression in the centre of the lymph heart. The expression of N- and R-cadherin was
detected as early as HH30, continued to be expressed until HH36 but, by HH38, expression of
these cadherins was not detected (Fig 3B1–3B4 and 3C1–3C4). Conversely, T-cadherin was
expressed throughout the lymph heart structure but, as with N- and R-cadherin, its expression
was not detected at HH38 and its overall expression was markedly weaker than M-cadherin
(Fig 3D1–3D4). Therefore, the cadherins also show a condensed programme of activation.
Furthermore, consistent with the lymphatic nature of the lymph heart, Prox-1 was also
expressed during development as reported previously (Fig 4A1–4A4) [11, 13, 21]. The expres-
sion of Prox-1 was evident throughout the lymph heart and its expression was noticeable from
HH30 and declined by HH38. We extended our study to investigate a marker for functional
mediation of muscle activity by examining localisation of L-type voltage gated channels, in
particular the Cav1.1 subunit, in the lymph heart. Surprisingly, we found that Cav1.1 was
expressed at a very early stage of lymph heart development (HH30) and, by HH38, its expres-
sion was confined to the edge of the lymph heart (Fig 4B1–4B4 and 4B1.1–4B1.4). Moreover,
we examined HCN channel expression and found that isoforms HCN1 and HCN4 were
expressed only at HH36 and not in other stages (Fig 5). We also examined the expression of
cardiac markers such as GATA-4 (data not shown) and, consistent with results reported in
amphibian lymph heart [11] did not detect any expression.
Developing Skeletal Muscle
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Effect of ion channel blockers on extracellular field potential
Our molecular profiling showed that the lymph heart predominantly expresses skeletal muscle
markers and therefore we set out to investigate the contribution of ion channels responsible
for excitation and contraction coupling in such tissue. Previous work has shown that the elec-
trical activity of the lymph heart resembles skeletal muscle and the mechanical activity of the
Fig 1. Expression of skeletal muscle markers during development of lymph heart. Whole mount in-situ
hybridisation showing developmental expression of Pax-7 (A1-A4), MyoD (B1-B4), Myogenin (C1-C4) and
Engrailed-1 (En-1) (D1-D4) in the lymph heart as indicated by red arrow. The expression of Pax-7, MyoD,
Myogenin and En-1 was detected as early as HH30 and declined by HH38.
doi:10.1371/journal.pone.0166428.g001
Developing Skeletal Muscle
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lymph heart is a result of the summation of bursts of acetylcholine-elicited postsynaptic poten-
tials [16]. In the present study, consistent with the skeletal muscle nature of the lymph heart,
the average peak to peak of the evoked local field potential (LFP) was significantly reduced to
43.1 ± 6.4% by the mixed mAChR and nAChR agonist, carbachol (10μM; p<0.001; Fig 6A–
6D). Interestingly, subsequent addition of the mAChR antagonist, atropine (5μM) reversed
the effects of carbachol, returning average peak-to-peak LFP amplitude to control levels (atro-
pine: 109.3 ± 8.5%; p>0.05; Fig 6C–6D). This finding is consistent with results reported previ-
ously [16] which showed that the electrical activity of lymph heart is sensitive to cholinergic
modulation. In addition, we also examined the effect of the sodium channel blocker, TTX
where application appeared to reduce average peak-to-peak amplitude to 73.3 ± 31.0% of con-
trol (133 ± 118%) although this difference was not statistically significant (p>0.05), most likely
due to the limited number of samples (n = 3; Fig 6E) and so necessitates future experiments to
implicate any involvement of voltage-gated sodium channels.
As shown above, the L-type Ca2+ channel in particular Cav 1.1 was expressed in the avian
lymph heart. In order to determine the contribution made by L-type Ca2+ channels to lymph
heart responsiveness, the effect of nifedipine (20μM), a selective blocker of voltage-gated L-
type Ca2+ channels [22], upon local field potentials evoked from lymph heart was investigated.
Nifedipine significantly reduced the average peak-to-peak LFP amplitude to 36.9 ± 2.6% com-
pared to control (p<0.001; Fig 7A1–7A3).
We next investigated ion channels that regulate rhythmicity such as T-type voltage-depen-
dent Ca2+ channels and HCN channels. In order to determine the presence of T-type channels
in avian lymph heart, mibefradil dihydrochloride (MD), a T–type voltage-operated Ca2+ chan-
nel antagonist, was used at a concentration of 10μM since higher concentrations can also
inhibit L-type Ca2+ channels [23]. Although block of L type Ca2+ channels cannot be excluded,
MD significantly reduced the average peak-to-peak evoked LFP amplitude to 33.9 ± 2.4% as
compared to control (p<0.001; Fig 7B1–7B3). However, since the magnitude of the block
observed was consistent with that seen following nifedipine treatment, these results show that
voltage operated Ca2+ channels, most likely L-type, are important in generating contractile
potentials in the avian lymph heart.
Fig 2. Expression of Engrailed-1 and M-cadherin during early avian development. Whole mount in-situ hybridisation
showing developmental expression of Engrailed-1 (En-1) (A1-A4) and M-cadherin (M-cad) (B1-B4) at HH14, HH22, HH24
and HH27. At HH-14 En-1 expression was only confined to the midbrain-hindbrain junction (indicated by asterisk (*) in A1).
At HH22 (A2 and B2) and HH24 (A3 and B3), En-1 expression is limited along the dorsal-ventral axis compared to M-cad (red
arrow). Furthermore, En-1 is not expressed in developing skeletal musculature of the head (black arrow), tongue muscle
(blue arrow) and limb muscle (green arrow) (A3-A4). In contrast to En-1, M-cad is expressed in skeletal musculature of the
head (black arrow), tongue muscle (blue arrow) and limb muscle (green arrow) (A4-B4).
doi:10.1371/journal.pone.0166428.g002
Developing Skeletal Muscle
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Sarcoplasmic reticulum (SR) Ca2+ transport ATPase (SERCA) is the largest single contribu-
tion to Ca2+ removal in skeletal and cardiac muscle. To test the hypothesis that Ca2+ refilling is
also crucial for the evoked potential seen in avian lymph heart, we recorded evoked LFPs first
in Ca2+ free buffer and subsequently in the presence of the SERCA pump blocker, cyclopiazo-
nic acid; (CPA; 10μM). As with nifedipine and MD, CPA significantly reduced the average
peak-to-peak LFP amplitude to 37.8 ± 10.7% compared to control p<0.05) and addition of
Fig 3. Expression of cadherins during lymph heart development. Whole mount in-situ hybridisation
showing developmental expression of M-cadherin (A1-A4), N-cadherin (B1-B4), R-cadherin (C1-C4) and T-
cadherin (D1-D4) in the lymph heart as indicated by red arrow. The expression of M, N, and R, and T-cadherin
was detected as early as HH30 and only M-cadherin was expressed at HH38.
doi:10.1371/journal.pone.0166428.g003
Developing Skeletal Muscle
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Fig 4. Expression of Prox-1, and Cav1.1 during lymph heart development. Whole mount in-situ hybridisation showing
developmental expression of Prox-1 (A1-A4) and Cav1.1 (B1-B4) in the lymph heart as indicated by red arrow. The
expression of Prox-1 and Cav1.1 was detected as early as HH30 and declined by HH38.
doi:10.1371/journal.pone.0166428.g004
Fig 5. Expression of HCN1 and HCN4 at HH36. Whole mount in-situ hybridisation showing expression of HCN1 and
HCN4 in avian lymph heart at HH36 as indicated by red arrow. The expression of these channels was not detected in other
stages.
doi:10.1371/journal.pone.0166428.g005
Developing Skeletal Muscle
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Ca2+ reversed the observed effect (161.4 ± 33.0%) where the average peak-to-peak LFP ampli-
tude was not only significantly different from CPA (p<0.001) but also from control (p<0.05;
Fig 8A–8D).
Optical recordings of lymph heart beating
In order to complement the developmental expression profile presented here, we also exam-
ined the functional innervation of the lymph heart. Particularly, we looked at E10, the stage at
which avian lymph heart exhibits spontaneous contraction [12]. In skinned pelvis (HH36),
lymph hearts contract at a rate of 5 beats per minute on heated stage (39–40˚C) as reported
previously [10]. ZD7288 is widely considered a selective blocker of HCN currents [24]. After
addition of ZD7288 (20μM), lymph heart continued to contract spontaneously at the same
rate and after 10 min of drug administration the spontaneous contraction declined to a rate of
2 beats per minute in all samples examined (n = 6). After 15 minutes of drug administration,
lymph hearts stopped contracting with no significant recovery observed after washing (Fig
9D). Furthermore, ZD7288 (20μM) significantly reduced the average peak-to-peak amplitude
of evoked LFP to 38.6 ± 8.6% compared to control (p<0.001; Fig 9A–9C). These data show
that the HCN channel is one of the candidates responsible for rhythmic contractions of the
lymph heart.
Fig 6. Evoked local field potential recorded from lymph heart before and after addition of carbachol followed by
atropine in the presence of carbachol. A) Representative trace of evoked local field potential (LFP) obtained from control,
in the presence of carbachol (10μM) B) and after adding atropine (5μM) in the presence of carbachol C). D) Bar charts show
average peak to peak of evoked LFP amplitude calculated from control, in the presence of carbachol and after adding
atropine in the presence of carbachol (n = 9). The data for evoked LFP in the presence of carbachol and the data for evoked
LFP of atropine in the presence of carbachol was normalised to data obtained from control. After adding carbachol the
average peak to peak of evoked LFP amplitude was significantly reduced (*** p<0.001) compared to the control. On
addition of atropine in the presence of carbachol the effects were significantly reversed (*** p<0.001). Error bars represent
mean ± SEM (n = 9). E) Bar chart shows average peak to peak of evoked LFP amplitude calculated from control, in the
presence of TTX (n = 3). The data for evoked LFP in the presence of TTX was normalised to data obtained from control. After
adding TTX the average peak to peak of evoked LFP was reduced compared to control however it was not statistically
significant (p>0.05). Error bars represent mean ± SEM.
doi:10.1371/journal.pone.0166428.g006
Developing Skeletal Muscle
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Taken together, these results suggest that lymph heart expresses functional mAChRs and
nAChRs in addition to a complement of ion channels which have known involvement in exci-
tation-contraction coupling and intrinsic rhythmicity.
Discussion
Musculature nature of lymph heart
Here, we examined the development of the avian lymph heart and electrophysiological proper-
ties using in situ hybridisation and MEA recordings respectively. Our molecular profiling
showed that the avian lymph heart is similar to skeletal muscle but has a distinct expression
profile of Pax-7, MyoD and Myogenin. We showed that Pax-7 is expressed at the same time as
Myogenin at HH30 and by HH38 there is a concomitant decline of Pax-7 and Myogenin. Dur-
ing development of other skeletal muscles, the expression of precursor genes such as Pax-7 is
Fig 7. Evoked local field potential recorded from lymph heart before and after addition of nifedipine and mibefradil
dihydrochloride. A1) Representative trace of evoked local field potential (LFP) obtained from control and in the presence
of nifedipine (20μM) (A2). A3) Bar charts show average peak to peak of evoked LFP amplitude calculated from control and
after adding nifedipine (n = 10). The data for evoked LFP in the presence of nifedipine was normalised to data obtained from
control. After adding nifedipine the average peak to peak of evoked LFP amplitude was significantly reduced (*** p<0.001)
compared to the control. Error bars represent mean ± SEM (n = 10). B1) Representative trace of evoked local field potential
(LFP) obtained from control and after adding mibefradil dihydrochloride (MD) (10μM) (B2). B3) Bar charts show average
peak to peak of evoked LFP amplitude calculated from control and after adding MD (n = 13). The data for the evoked LFP in
the presence of MD was normalised to data obtained from control. After adding MD the average peak of evoked LFP
amplitude was significantly reduced (*** p<0.001) compared to the control. Error bars represent mean ± SEM (n = 13).
doi:10.1371/journal.pone.0166428.g007
Developing Skeletal Muscle
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Fig 8. Evoked local field potential recorded from lymph heart before and after addition of cyclopiazonic acid
followed by calcium. A) Representative trace of evoked local field potential (LFP) obtained from control, in the presence of
CPA (10μM) B) and after adding Ca2+ (2mM) C). D) Bar charts show average peak to peak of evoked LFP amplitude
calculated from control, in the presence of CPA and after adding Ca2+ (n = 13). The data for the evoked LFP in the presence
of CPA and the data for the evoked LFP of Ca2+ was normalised to data obtained from control. After adding CPA the average
peak to peak of evoked LFP amplitude was significantly reduced (* p<0.05) compared to control. On addition of Ca2+ the
average peak to peak of evoked LFP amplitude significantly increased compared to CPA (*** p<0.001) and control
(* p<0.05). Error bars represent mean ± SEM (n = 13).
doi:10.1371/journal.pone.0166428.g008
Developing Skeletal Muscle
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temporally and spatially separated from expression of markers of terminal skeletal muscle dif-
ferentiation [25]. We also showed that Pax-7 and Myogenin are co-expressed at early stage of
HH30 in the lymph heart development. The co-expression, however, of Pax-7 and MyoD, in
the lymph heart is reminiscent of activated skeletal muscle cells [23]. From the expression pro-
files of Pax-7, MyoD and Myogenin, it appears that the process of myogenesis is not dynamic as
is seen in skeletal muscle. Thus, in contrast to skeletal muscle, the processes of proliferation
and differentiation do not appear to be mutually exclusive in lymph heart, suggesting that the
development of the functional lymph heart may not necessarily be a subdivided process of pro-
liferation and differentiation. We therefore suggest that the process of simultaneous prolifera-
tion and differentiation accelerates the development of the lymph heart, allowing it to become
fully functional rapidly enough to successfully execute its essential role during in ovo life. The
Fig 9. Evoked local potential recorded from lymph heart before and after addition of ZD7288 and effect
of ZD7288 on lymph heart beating. A) Representative trace of evoked local field potential (LFP) obtained
from control and in the presence of ZD7288 (20μM) (B). C) Bar charts show average peak to peak of evoked
LFP amplitude calculated from control and after adding ZD7288 (n = 11). The data for the evoked LFP in the
presence of ZD7288 was normalised to data obtained from control. After adding ZD7288 the average peak to
peak of evoked LFP amplitude was significantly reduced (*** p<0.001) compared to the control. Error bars
represent mean ± SEM (n = 11). D) Representative trace obtained by plotting z-axis profile of lymph heart
beating. The arrow on the left indicates the time at which ZD7228 is added. The lymph heart beating declined
with time and eventually stopped beating completely as indicated on the trace.
doi:10.1371/journal.pone.0166428.g009
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accelerated development of this skeletal muscle is also shown by the premature and overlap-
ping expression of the cadherins and formation of the endothelial compartment (Prox1). We
have previously shown that rapid transition from proliferation into differentiation is capable
of accelerating development but has a major impact on muscle mass development by depleting
the precursors required for sustained tissue growth [23] although we propose that this is not a
risk factor in the avian lymph heart since it is only required for a short period of embryonic
life.
Another important feature of avian lymph heart is the expression of En-1. Here we show
that En-1 is restricted to the epaxial region of dermomyotomes [26]. In zebra fish, En-1 is
expressed in the medial cells, known as adaxial cells, which subsequently migrate radially away
from the notochord, becoming a superficial layer of muscle cells [25, 27]. Our in-situ hybridi-
sation results showed that at HH30, En-1 specifically marked lymph heart myoblasts and not
any other type of myoblasts. We have shown previously that lymph heart develops from the
hypaxial regions [10] and our results show that En-1 is only expressed in the epaxial compart-
ments during development suggesting that the expression of En-1 represents a de novo specifi-
cation event and not simply a trace from its somitic origin. Secondly, the expression of En-1 is
dependent on Hedgehog (Hh) signalling in Xenopus lymph heart and in the absence of Hh sig-
nalling and upon En-1 knockdown, lymph heart muscle fails to develop and embryos conse-
quently develop oedema [11]. Our results however, failed to detect expression of Sonic
Hedgehog (Shh; data not shown) in avian lymph heart suggesting that the mechanisms that reg-
ulate En-1 in avian lymph heart are different from the ones reported in Xenopus [11].
Muscle contraction is regulated by elevation of the intracellular Ca2+ concentration medi-
ated by the interplay between two membrane proteins, the L-type voltage-gated calcium chan-
nels, VGCCs, and ryanodine receptors, RyRs. Here, we examined the expression of Cav1.1
during development of the lymph heart and our results showed that the expression profile of
Cav1.1 is similar to skeletal muscle markers (Pax-7 and MyoD). However, it was surprising
that the expression of Cav1.1 was evident in lymph heart at HH30. These results show that
development of the lymph heart does not show the stepwise changes from precursor, to com-
mitted, to functionally active states which is seen during axial and limb development. Instead
there is an accelerated process of development in which these events occur concurrently. We
suggest that this hastened development is required in order for the lymph heart to become rap-
idly functional in a short space of time from its induction to the point at which it becomes
redundant.
Interestingly, we also revealed expression of isoforms of HCN channels, namely HCN1 and
HCN4. The expression of these channels coincides with the lymph heart exhibiting spontane-
ous contractions [12]. These two isoforms are also prominently expressed in the sino-atrial
node suggesting that the mechanism underlying spontaneity of contraction in the lymph heart
is similar to the blood heart. However, future studies examining blockade of HCN channels
directly with siRNA may shed further light in the role of HCN channels and spontaneous
activity of the lymph heart.
Electrical activity of lymph heart
In our pharmacological investigations, the lymph heart was driven electrically in order to
reduce variability in responsiveness commonly observed when recording bioelectrical activity
in spontaneously beating organs. We examined electrically evoked local field potentials as a
reliable indicator of the spontaneous activity in the lymph heart [14–16] to test the hypothesis
that specific receptor types and ion channels regulate excitability of lymph heart. Carbachol, a
parasympathomimetic drug that acts as an agonist at both muscarinic (mAChR) and nicotinic
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(nAChR) acetylcholine receptors, significantly reduced peak-to-peak evoked LFP amplitude;
an effect that could be fully reversed by the mAchR antagonist, atropine consistent with previ-
ous reports [16]. Previous studies have showed that neuromuscular junctions at chick lymph
heart muscle fibres exhibit acetylcholinesterase activity [10, 11] which diminishes as afferent
innervation to the lymph heart degrades during late development [10]. Here, the role of lymph
heart nAChR appear analogous to skeletal muscle as their stimulation causes muscular con-
traction. On the other hand, the mAChR acts as inhibitory cholinergic nerves similar to the
vagal endings in the blood heart [28].
Pharmacological block of L-type Ca2+ channels significantly reduced peak-to-peak LFP
amplitude and this channel is most likely responsible for excitation-contraction coupling in
the lymph heart as has been reported for skeletal, smooth and cardiac muscle. Transmission
electron microscopy has shown that, at E10, the muscular layer of lymph heart consisted of
myoblasts containing largely immature contractile myofilaments with few Z disc striations
[10] making it likely that, as with skeletal muscle, L-type Ca2+ channels in the avian lymph
heart are also located in the T-tubules. In addition, in skeletal muscle, most Ca2+ that activates
contraction originates from the sarcoplasmic reticulum and SERCA is considered to play a
major role in Ca2+ removal during relaxation [29] 30. Our results showed that blocking the
SERCA pump in the avian lymph heart with CPA significantly reduced peak-to-peak LFP
amplitude. We propose that here, as with skeletal muscle and during excitation-contraction
coupling of the lymph heart, L-type Ca2+ channels act as a voltage sensors with conformational
changes leading to a physical interaction with ryanodine receptors (RyRs), promoting its open-
ing, and triggering the release of Ca2+ from internal stores to cause a global Ca2+ transient.
This leads to activation of SERCA which pumps Ca2+ back into the sarcoplasmic reticulum
and inactivates RyRs. Future experiments to examine the expression of RyR1 and RyR2 are
warranted and would provide greater insight on the role of ryanodine receptors during
dynamic Ca2+ handling events in development of lymph heart. It should however be noted
that the mechanism governing excitation-contraction coupling we describe here is the most
simplistic and could be further modulated by the involvement of proteins such as calmodulin
[30] and triadin [31], the potential role of which remain to be examined.
The mechanism described above for excitation-contraction coupling is insufficient to
explain the rhythmic contractions seen in the lymph heart. Therefore, we also explored the
potential contribution of other ion channels such as T-type Ca2+ channels and HCN channels.
Since we cannot exclude the possibility that MD may also cause a block of L-type channels at
the concentration used, we cannot conclude the exclusive involvement of T-type channels in
the regulation of avian lymph heart rhythmicity although our results do implicate such
involvement. Confirmation of our findings via investigation of the expression profile of T-type
Ca2+ channels during development of lymph heart is warranted. Another candidate to explain
the rhythmic contractions of the avian lymph heart is the HCN channel. The hyperpolarisa-
tion-activated current (Ih) is a mixed cationic current carried by Na
+ and K+ and recent evi-
dence for small but significant Ca2+ permeability of these channels [32]. The role of HCN
channels has been well documented in pace-making cells in the sinoatrial node and in the
brain [33]. Ih is activated by hyperpolarisation to potentials negative to -50 to -60mV and inac-
tivates upon depolarisation. Because membrane potential depolarises upon HCN activation,
these channels can serve as pacemakers and modulate resting membrane potential and mem-
brane properties of spontaneously active cells. Our results showed that HCN channels are
responsible for the rhythmic contractions of the lymph heart as application of ZD7288, at
20μM to minimise off-target effects [34], irreversibly abolished lymph heart beating. Further
support for the existence of HCN channels in modulating rhythmic contractions is provided
by our MEA data where ZD7288 significantly reduced peak-to-peak LFP amplitude. While the
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precise localisation of these channels requires further investigation, it is known that among
striated muscle fibres there are contracting-filament-fibres which resemble the bundle of His
of blood heart in the lymph heart [33] making it likely that these channels are located in that
area.
The presence of HCN channels in lymphatics has been reported previously, for instance, a
study by McCloskey et al., [35] showed the presence of hyperpolarization-activated inward
current similar to the one seen in sinoatrial node cells in the heart. Interestingly, this current
was found only in 5% of the cells studied, suggesting the existence of specialized pacemaker
cells in these vessels [35]. Further support for the existence of pacemaker cells in the lymphat-
ics is provided by recent demonstration of a subpopulation of cells lying below the endothe-
lium in mesenteric lymphatics. These cells show many of the immunohistochemical and
ultrastructural features of the pacemaker cells [32].
Conclusions
Our molecular data suggests that the developmental programme utilised by the avian lymph
heart is suited for the rapid development of a functional organ at the expense of generating
mass (Fig 10). Furthermore, we provide evidence based on En-1 expression that it is homolo-
gous to the structure found in amphibians. Our microelectrode array results show that the
avian lymph heart is sensitive to cholinergic and L-type Ca2+ channel blockers suggesting that
cholinergic receptors and L-type Ca2+ channels are most likely important in excitation and
Fig 10. Summary of the genes regulated during lymph heart development and involvement of ion channels in
excitability and rhythmicity of the lymph heart. The lymph heart predominantly expresses skeletal muscle markers and
their expression is evident as early as HH30 and declines by HH38. By HH36, the lymph heart contracts rhythmically and the
basis for their underlying rhythmicity is most likely mediated by HCN channels while their excitation and contraction coupling
is facilitated by cholinergic and L-type Ca2+ channels.
doi:10.1371/journal.pone.0166428.g010
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contraction coupling. In addition, our results showed that HCN channels, contribute to main-
tenance of avian lymph heart rhythmicity. Therefore, the pathways implicated in regulating
excitation and contraction coupling seem to operate independently of those regulating rhyth-
micity of the lymph heart. Taken together, these findings reveal unique insights into the devel-
opmental changes that give rise to lymph heart rhythmicity and so provide new avenues for
experimental manipulation in cardiac bioengineering.
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